drugset / Trial / NCT00944632

Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis

NCT00944632

Phase 2 Completed 64 enrolled Bayer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of three concentrations of ZK 245186 ointment and vehicle on increasing body surface areas for the treatment of atopic dermatitis and to obtain dose-response information for the three concentrations.

Timeline

Start
2009-07-15
Primary completion
2010-09-15
Completion
2010-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mapracorat Small molecule 0.01 % Topical
Comparator Mapracorat Small molecule 0.03 % Topical
Comparator Mapracorat Small molecule 0.1 % Topical

Indications